サーモフィッシャーは2025年第4四半期の決算予想を上回り、配当を増やし、経営陣の株式売却にもかかわらず株価上昇を記録しました。 Thermo Fisher beat earnings estimates in Q4 2025, raised its dividend, and saw stock gains despite executive share sales.

Thermo Fisher Scientific Inc. (TMO) は,6.57ドルのEPSで,推定値を0.12ドル上回り,年間7.2%の売上高を12.22億ドルで,強力なQ4 2025の利益を発表しました. Thermo Fisher Scientific Inc. (TMO) reported strong Q4 2025 earnings with $6.57 EPS, beating estimates by $0.12, and revenue of $12.22 billion, up 7.2% year-over-year. 株価は第3四半期に8.2%上昇し,リンクルーデンマネジメント株式会社とホロセーンアドバイザーズLPとNEO Investment Management LLCの新規投資により増加した. The stock rose 8.2% in the third quarter, driven by increased holdings from Lincluden Management Ltd. and new investments from Holocene Advisors LP and NEOS Investment Management LLC. CEOのマーク・キャスパーは3月4日に5000株を3. 8%削減した一方,副社長のポール・K・L・チウも株式を売却した. CEO Marc Casper sold 5,000 shares on March 4, reducing his stake by 3.88%, while Executive Vice President Paul K. L. Chiu also sold shares. 会社は3月13日の配当期限と4月15日の支払いを定め,四半期配当を0.47ドルに増額した. The company raised its quarterly dividend to $0.47, with an ex-dividend date of March 13 and payment on April 15. 分析官は,平均目標633.68ドルを目標に,"モデレート・バイヤー"の評価率を維持している. Analysts maintain a "Moderate Buy" consensus rating with an average target of $633.68.